Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2012 | 2012 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2012 | 2012 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2010 | 2016 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 12 | 68160508 | intron variant | G/A;C | snv |
|
Infections; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.120 | 12 | 68160508 | intron variant | G/A;C | snv |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.763 | 0.320 | 12 | 68154443 | intron variant | T/A;C | snv |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.763 | 0.320 | 12 | 68154443 | intron variant | T/A;C | snv |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.763 | 0.320 | 12 | 68154443 | intron variant | T/A;C | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.763 | 0.320 | 12 | 68154443 | intron variant | T/A;C | snv |
|
0.010 | 1.000 | 1 | 2010 | 2010 |